Necs Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Navi Mumbai, Maharashtra, India, established in 2016.
2016 Navi Mumbai, Maharashtra, India Active
Last Updated:
About Necs Pharma Llp

Necs Pharma Llp, a active limited liability partnership, was established on 16 September 2016 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAH-4081. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Employing 128 professional, Its leadership includes Rachit Bharat Dave (Designated Partner), Sankaranarayanamoorthy Muthukrishnan (Designated Partner). It holds ₹4.44 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at Flat No. 201, Plot - 2, Twinkle Co-Op Hsg Sty, Sector - 19, Neru, L, Navi Mumbai, Maharashtra, 400706.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAH-4081

  • Incorporation Date

    16 September 2016

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 9 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.44 Cr
  • Revenue Growth **** 251.29%
  • Profit Growth **** 698.59%
  • Ebitda **** -261.82%
  • Total Assets **** 52.87%
Company report

Necs Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Necs Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Necs Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Rachit Bharat Dave Designated Partner 16 Sep 2016 Current
Sankaranarayanamoorthy Muthukrishnan Designated Partner 16 Sep 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Necs Pharma Llp.

Necs Pharma Llp, for the financial year ended 2023, experienced significant growth in revenue, with a 251.29% increase. The company also saw a substantial improvement in profitability, with a 698.59% increase in profit. The company's net worth witnessed no change by increase of 0%.

Necs Pharma Llp revenue growth over time
Necs Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
251.29%
*******
*******
*******
*******
Revenue from Operations
*******
250.63%
*******
*******
*******
*******
Total Assets
*******
52.87%
*******
*******
*******
*******
Profit or Loss
*******
698.59%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
-261.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Necs Pharma Llp?

Unlock access to Necs Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹44,424,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of Baroda : 4.44 Cr
Latest Charge Details
Date Lender Amount Status
02 Feb 2022 Bank Of Baroda ₹1.72 M Open
04 May 2020 Bank Of Baroda ₹1.00 M Open
11 Oct 2018 Bank Of Baroda ₹4.17 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Necs Pharma Llp?

Necs Pharma Llp has a workforce of 78 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Necs Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Necs Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Necs Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Necs Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Necs Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Charges

    Progress on A charge with Bank Of Baroda of Rs. 41.70 M registered on 11 Oct 2018 with Charge ID 100214618 was modified on 19 May 2022. was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 1.72 M with Charge ID 100532131 was registered on 02 Feb 2022. was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 1.00 M with Charge ID 100403706 was registered on 04 May 2020. was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 41.70 M with Charge ID 100214618 was registered on 11 Oct 2018. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Necs Pharma Llp?

The LLPIN of Necs Pharma Llp is AAH-4081.

Where is Necs Pharma Llp headquartered?

Necs Pharma Llp is headquartered at Flat No. 201, Plot - 2, Twinkle Co-Op Hsg Sty, Sector - 19, Neru, L, Navi Mumbai, Maharashtra, 400706.

When was Necs Pharma Llp incorporated?

Necs Pharma Llp was incorporated on 16 September 2016.

Who are the current directors of Necs Pharma Llp?

The current directors of Necs Pharma Llp are

What is the primary industry of Necs Pharma Llp?

The primary industry of Necs Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available